Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
Top Cited Papers
- 31 May 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Neurosciences
- Vol. 31 (5), 234-242
- https://doi.org/10.1016/j.tins.2008.02.005
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Psychosis: Atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?Epilepsy & Behavior, 2007
- The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and PlasticityNeuron, 2007
- DTNBP1 genotype influences cognitive decline in schizophreniaSchizophrenia Research, 2007
- A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of SchizophreniaBiological Psychiatry, 2006
- Serine racemase binds to PICK1: potential relevance to schizophreniaMolecular Psychiatry, 2005
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 2004
- NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humansSynapse, 2001
- Smoking and Vulnerability for SchizophreniaSchizophrenia Bulletin, 1996
- Methylazoxymethanol Treatment of Fetal Rats Results in Abnormally Dense Noradrenergic Innervation of NeocortexScience, 1979